ReNeuron Group Company

Stroke oriented, stem cell therapies. Primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
01.01.1997
Employees Number:
51-100
Funding Status:
IPO
Acquisitions Number:
1
Investors Number:
4
Total Funding:
167 333 065
Estimated Revenue:
$1M to $10M
Last Funding Date:
10.07.2015
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership